Search research articles
Contact Us
Filters
Showing results (301-310 of 358) with videos related to
Page
of 36
Sort By:
Antiviral Therapy
|
September 9, 2011
Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART
Emanuele Nicastri, Chiara Tommasi, Isabella Abbate, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 2, 2021
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma
Amedeo De Nicolò, Alessandra Manca, Alice Ianniello, et al.
British Journal of Clinical Pharmacology
|
May 15, 2021
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia
Silvia Corcione, Amedeo De Nicolò, Giorgia Montrucchio, et al.
Influenza and Other Respiratory Viruses
|
August 10, 2013
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
Tina Ruggiero, Francesco De Rosa, Francesco Cerutti, et al.
AIDS (London, England)
|
January 5, 2019
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants
Luca Bertero, Sarah Beth Joseph, Mattia Trunfio, et al.
Medicina (Kaunas, Lithuania)
|
August 8, 2019
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
Davide Giuseppe Ribaldone, Alessandro Adriani, Gian Paolo Caviglia, et al.
Pharmacogenetics and Genomics
|
January 11, 2011
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism
Marco Siccardi, Antonio D'Avolio, Silvia Nozza, et al.
Antiviral Therapy
|
April 28, 2006
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients
Andrea Antinori, Maria Paola Trotta, Paola Nasta, et al.
Antiviral Research
|
June 24, 2014
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner
Amedeo De Nicolò, Lucio Boglione, Alessia Ciancio, et al.
Clinical Pharmacokinetics
|
August 2, 2020
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV
Andrea Calcagno, José Moltó, Alberto Borghetti, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 358) with videos related to
Sort By:
Page
of 36
Antiviral Therapy
|
September 9, 2011
Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART
Emanuele Nicastri, Chiara Tommasi, Isabella Abbate, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 2, 2021
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma
Amedeo De Nicolò, Alessandra Manca, Alice Ianniello, et al.
British Journal of Clinical Pharmacology
|
May 15, 2021
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia
Silvia Corcione, Amedeo De Nicolò, Giorgia Montrucchio, et al.
Influenza and Other Respiratory Viruses
|
August 10, 2013
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
Tina Ruggiero, Francesco De Rosa, Francesco Cerutti, et al.
AIDS (London, England)
|
January 5, 2019
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants
Luca Bertero, Sarah Beth Joseph, Mattia Trunfio, et al.
Medicina (Kaunas, Lithuania)
|
August 8, 2019
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
Davide Giuseppe Ribaldone, Alessandro Adriani, Gian Paolo Caviglia, et al.
Pharmacogenetics and Genomics
|
January 11, 2011
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism
Marco Siccardi, Antonio D'Avolio, Silvia Nozza, et al.
Antiviral Therapy
|
April 28, 2006
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients
Andrea Antinori, Maria Paola Trotta, Paola Nasta, et al.
Antiviral Research
|
June 24, 2014
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner
Amedeo De Nicolò, Lucio Boglione, Alessia Ciancio, et al.
Clinical Pharmacokinetics
|
August 2, 2020
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV
Andrea Calcagno, José Moltó, Alberto Borghetti, et al.
Page
of 36